APELOA PHARMACEUTICAL CO., LTD. – Trademark Portfolio

Entity Type: 99

APELOA PHARMACEUTICAL CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include APELOA and YOSEMADE. The owner is based in DONGYANG CITY,ZHEJIANG.

No. 399, JIANGNAN ROAD, HENGDIAN TOWN

DONGYANG CITY,ZHEJIANG 00000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #88878634
Registered 2020
YOSEMADE
YOSEMADE
Registered 2020
APELOA
APELOA
Registered 2020

Trademark Classifications

APELOA PHARMACEUTICAL CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does APELOA PHARMACEUTICAL CO., LTD. have?

APELOA PHARMACEUTICAL CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does APELOA PHARMACEUTICAL CO., LTD. file in?

APELOA PHARMACEUTICAL CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are APELOA PHARMACEUTICAL CO., LTD.'s most well-known trademarks?

APELOA PHARMACEUTICAL CO., LTD.'s registered trademark portfolio includes well-known marks such as APELOA and YOSEMADE. These are among 3 currently registered trademarks in the portfolio.

What is APELOA PHARMACEUTICAL CO., LTD.'s trademark registration success rate?

APELOA PHARMACEUTICAL CO., LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.